Jack Schroeder and Asscociates, Inc – Trademark Portfolio
Entity Type: 03
Jack Schroeder and Asscociates, Inc holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include JSA and DESTINATION MEDICARE. The owner is based in Green Bay, WI.
2064 Allouez Ave
Green Bay, WI 54311
Showing of trademarks Trademarks
Trademark Classifications
Jack Schroeder and Asscociates, Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Jack Schroeder and Asscociates, Inc have?
Jack Schroeder and Asscociates, Inc has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Jack Schroeder and Asscociates, Inc file in?
Jack Schroeder and Asscociates, Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Jack Schroeder and Asscociates, Inc's most well-known trademarks?
Jack Schroeder and Asscociates, Inc's registered trademark portfolio includes well-known marks such as JSA and DESTINATION MEDICARE. These are among 2 currently registered trademarks in the portfolio.
What is Jack Schroeder and Asscociates, Inc's trademark registration success rate?
Jack Schroeder and Asscociates, Inc has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.